Law firm Bleichmar Fonti & Auld LLP announced on November 17, 2026, that a securities fraud class action lawsuit captioned Perusek v. The Ensign Group, Inc., et al., No. 8:26-cv-02963, has been filed against The Ensign Group, Inc. and certain of its senior executives in the U.S. District Court for the Central District of California.

Key Highlights

  • Lead plaintiff deadline: Investors have until December 7, 2026 to ask the court to be appointed to lead the case.
  • Largest alleged stock drop: Ensign shares fell $13.88 per share, or 8.15%, on June 8, 2026, closing at $156.42 from a prior close of $170.30.
  • Second alleged drop: Shares fell $4.52 per share, or 2.98%, on June 11, 2026, closing at $147.13 from a prior close of $151.65.
  • Third alleged drop: Shares fell $2.19 per share, or 1.4%, closing at $153.65 on June 18, 2026.
  • Legal basis: The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
  • Alleged misconduct: The complaint alleges concealment of understaffing, patient neglect, manipulated quality and staffing data, improper billing, and an administrator-license rental scheme.

Allegations Against The Ensign Group and Related Stock Price Declines

According to the announcement by Bleichmar Fonti & Auld LLP, the class action targets The Ensign Group, Inc. (NASDAQ:ENSG), a healthcare services company that the filing describes as operating skilled nursing, senior living, and rehabilitative care facilities through affiliated providers. The company, the announcement notes, "relies heavily on Medicare and Medicaid reimbursements, making patient care, staffing, billing, and regulatory compliance central to its business model."

The complaint, as described in the announcement, alleges that defendants "concealed systematic understaffing and patient neglect, manipulated reported quality and staffing data, engaged in improper Medicare and Medicaid billing and upcoding, and used licensed administrators who did not actually manage certain facilities." The announcement attributes three separate stock price declines to the publication of outside investigative reports. On June 8, 2026, Hunterbrook Media published a report titled "Ensign: The Nursing Home Empire Built on Fatal Neglect," following which shares fell 8.15%. On June 11, 2026, Muddy Waters Research published a report alleging that Ensign used licensed administrators who were "seldom present" and that the alleged practices existed at approximately 20% of Ensign's skilled nursing facilities. Shares fell 2.98% on that date. On June 18, 2026, Hunterbrook published a follow-up report alleging additional evidence of understaffing and data falsification, and shares fell 1.4%.

The case is pending as Perusek v. The Ensign Group, Inc., et al., No. 8:26-cv-02963, in the U.S. District Court for the Central District of California. The announcement was issued by Bleichmar Fonti & Auld LLP and is labeled as attorney advertising. It states that "past results do not guarantee future outcomes."

What Was Disclosed

Law firm Bleichmar Fonti & Auld LLP announced the filing of a securities fraud class action against The Ensign Group, Inc. and certain senior executives, citing alleged misrepresentations about patient care, staffing, billing, and regulatory compliance, with a lead plaintiff deadline of December 7, 2026.